fig2
![Emerging resistance <i>vs.</i> losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena](https://image.oaes.cc/db6e1092-49b5-4b8e-9293-a178390c73e6/cdr6047.fig.2.jpg)
Figure 2. Types of resistance. ICI: Immune checkpoint inhibitor; IRAE: immune-related adverse events; RCC: renal cell carcinoma. (Figure credits: Roy AM).
Figure 2. Types of resistance. ICI: Immune checkpoint inhibitor; IRAE: immune-related adverse events; RCC: renal cell carcinoma. (Figure credits: Roy AM).
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/